Correspondence 0001213900-22-080079 from Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114) (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO) (CIK 0001814114)
Date: Dec. 15, 2022 · CIK: 0001814114 · Accession: 0001213900-22-080079
AI Filing Summary & Sentiment
File numbers found in text: 333-266660
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences RE: Health Sciences Acquisitions Corporation 2 Amendment No. 4 to Registration Statement on Form S-4 Filed December 13, 2022 File No. 333-266660
Dear Ms. Gama and Ms. Yale:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant, Health Sciences Acquisitions Corporation 2, hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on December 16, 2022, or as soon as practicable thereafter.
Very truly yours,
HEALTH SCIENCES ACQUISITIONS CORPORATION 2
Show Raw Text
CORRESP
1
filename1.htm
Health Sciences Acquisitions Corporation 2
40 10th Avenue, Floor 7
New York, NY 10014
December 15, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Doris Stacey Gama
Dorrie Yale
RE:
Health Sciences Acquisitions Corporation 2
Amendment No. 4 to Registration Statement on Form S-4
Filed December 13, 2022
File No. 333-266660
Dear Ms. Gama and Ms. Yale:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
the registrant, Health Sciences Acquisitions Corporation 2, hereby requests acceleration of effectiveness of the above-referenced Registration
Statement so that it will become effective at 5:00 p.m. Eastern Time on December 16, 2022, or as soon as practicable thereafter.
Very truly yours,
HEALTH SCIENCES ACQUISITIONS CORPORATION 2
By:
/s/ Roderick Wong
Roderick Wong, MD
Chief Executive Officer